ctrl K

Price Alert

Cerevel Therapeutics Inc... (CERE)

NASDAQ: CERE · Real-Time Price · USD

44.96

0.33 (0.74%)

At close: Jul 31, 2024, 10:00 PM

Cerevel Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	990.97M	136.52M	193.02M
Short-Term Investments	574.5M	755.51M	372.67M
Long-Term Investments	187.16M	58.13M	52.27M
Other Long-Term Assets	3.43M	4.76M	6.93M
Receivables	5.29M	n/a	729K
Inventory	n/a	-2.05M	-729K
Other Current Assets	10.68M	13.62M	12.33M
Total Current Assets	1.01B	905.65M	578.02M
Property-Plant & Equipment	45.77M	49.29M	51.7M
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	236.36M	112.17M	110.9M
Total Assets	1.24B	1.02B	688.92M
Account Payables	11.86M	10.06M	11.3M
Deferred Revenue	n/a	n/a	28.43M
Short-Term Debt	3.4M	2.9M	2.44M
Other Current Liabilities	76.91M	59.6M	28.8M
Total Current Liabilities	92.18M	72.56M	42.54M
Long-Term Debt	365.21M	366.67M	34.11M
Other Long-Term Liabilities	112.16M	57.35M	33.54M
Total Long-Term Liabilities	477.37M	424.02M	67.65M
Total Liabilities	569.55M	496.58M	110.19M
Total Debt	480.78M	366.67M	36.55M
Common Stock	18K	16K	15K
Retained Earnings	-1.4B	-967.75M	-616.24M
Comprehensive Income	1.77M	3.1M	-986K
Shareholders Equity	673.75M	521.24M	578.73M
Total Investments	187.16M	813.63M	424.94M